AGT and hypertensive disorder: Urinary angiotensinogen (uAGT) is a novel biomarker of the activation of the renin–angiotensin system (RAAS) in patients with ADPKD, and it is associated with hypertension, progressive kidney damage, proteinuria, and cardiovascular morbidity and mortality.